Why is turmeric powder not equivalent to a curcumin supplement?

Raw turmeric contains 3–5% curcuminoids by weight. Curcumin has less than 1% oral bioavailability without absorption enhancers — it is rapidly glucuronidated and sulfated in the intestinal wall and liver. A teaspoon of turmeric (3g) delivers approximately 150mg curcuminoids, of which perhaps 1–2mg reaches systemic circulation. A 500mg curcumin extract with BioPerine (piperine) or a phospholipid complex (BCM-95) delivers 20–40mg to systemic circulation. The anti-inflammatory RCT evidence was generated with enhanced-bioavailability curcumin, not raw turmeric powder.

What dose of Bacopa monnieri actually works for memory?

Standardised Bacopa extract at 300mg/day (45% bacosides) or 450mg/day (20% bacosides) is the clinically studied range. Effects on delayed recall memory appear at 8–12 weeks of consistent daily dosing — Bacopa is not an acute nootropic. Roodenrys et al. (2002) and Stough et al. (2001) both used standardised extracts at these doses. Generic brahmi churna at traditional doses has not been tested in equivalent double-blind RCTs.

Is berberine as effective as metformin for blood sugar?

Three head-to-head RCTs have found berberine comparable to metformin 500mg three times daily for HbA1c reduction in type 2 diabetics. Zhang et al. (2008) is the most-cited: identical HbA1c reduction (−0.9%) and fasting glucose reduction (−1.0 mmol/L) in a 3-month trial. The mechanism is different — berberine activates AMPK and also directly inhibits mitochondrial complex I. Berberine is not a regulated pharmaceutical; for clinical diabetes management, metformin under physician supervision remains the standard.

What is the difference between AYUSH-registered and FSSAI-registered herbal products?

AYUSH (Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homeopathy) regulates traditional Ayurvedic formulations — including churnas, arishtas, and kashayas — under the Drugs and Cosmetics Act. These products are permitted to claim traditional Ayurvedic use. FSSAI regulates herbal supplements sold as nutraceuticals — these must meet the Health Supplements Regulations 2022, which prohibit therapeutic drug claims and require GMP compliance. A product cannot claim to 'treat' a disease under FSSAI. Many Indian herbal brands straddle both: AYUSH registration for traditional products, FSSAI for standardised extracts. The distinction matters for efficacy claims: AYUSH approval signals traditional use, not clinical evidence.

Is Brahmi the same as Bacopa monnieri?

Brahmi is a common name applied to two different plants in Indian tradition: Bacopa monnieri (the plant used in cognitive RCTs, also called water hyssop) and Centella asiatica (gotu kola, also sometimes called mandukparni). Most modern standardised 'Brahmi' cognitive supplements use Bacopa monnieri. Some traditional Ayurvedic brahmi preparations use Centella asiatica. When buying a standardised extract for memory, confirm the Latin name is Bacopa monnieri and that bacosides (A+B) are standardised and declared on the label.

Home/Compare/Herbal Supplements India 2026

Independent · India-market · 85 products scored · May 2026

Best Herbal Supplements India 2026 — Curcumin, Bacopa, Berberine & More

India grows most of the world's medicinal herbs. India's supplement market for those herbs is dominated by churnas and unstandardised powders with borrowed clinical claims. This page separates what the RCTs actually studied — standardised extracts at verified doses — from what most Indian brands actually sell.

The core problem across this entire category

Curcumin from raw turmeric has <1% oral bioavailability. Bacopa churna has no RCT support at traditional doses. The clinical evidence for every herb on this page was generated using standardised extracts at specific concentrations — not the churna, not the "haldi milk," not the 20-herb Ayurvedic formulation. Buying the raw powder and expecting the RCT outcome is like buying flour and expecting bread. Standardisation percentage and absorption enhancer are the two purchasing decisions that determine whether you're getting the compound that was tested.

RCT strength: Curcumin — Strong Bacopa — Strong Berberine — Strong Shatavari — Moderate Boswellia — Moderate Moringa — Moderate Triphala — Limited Amla — Limited Giloy — Limited

Curcumin: <1% bioavailability without enhancer Berberine: head-to-head vs metformin in 3 RCTs Bacopa: 8–12 weeks for memory effects — not acute AYUSH approval = traditional use, NOT clinical evidence FSSAI Schedule I / III regulated Updated May 2026

Curcumin + BioPerine vs raw turmeric

2,000%

Increase in curcumin bioavailability from adding 5mg piperine (BioPerine) to 500mg curcumin

Shoba et al. (1998), Planta Medica — landmark pharmacokinetic study. The same group in the same paper: maximum serum curcumin was undetectable in the non-piperine group. This is the foundational evidence for why "haldi supplements" without an absorption enhancer deliver essentially no systemic curcumin. Phospholipid complexes (BCM-95, Meriva) achieve similar absorption via a different mechanism. RCT

The churna problem — across every herb

High-quality RCTs on traditional churna or unstandardised herb powder for any clinical outcome

Churna preparations vary 3–10× in active compound concentration batch to batch. No regulatory standard sets minimum active compound content. Clinical trial protocols cannot be replicated on uncharacterised material. The RCT evidence for Bacopa on memory, curcumin on inflammation, berberine on blood glucose — all of it was generated with standardised extracts. The churna and the standardised extract are not interchangeable. Observational only

How the top three work

Curcumin: NF-κB inhibitor with a critical bioavailability problem

Curcumin (diferuloylmethane) — the primary active curcuminoid in turmeric — inhibits the NF-κB (nuclear factor kappa B) signalling pathway by blocking IκBα phosphorylation and preventing NF-κB nuclear translocation. NF-κB is the master regulator of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β, COX-2). Curcumin also directly inhibits COX-2 (cyclooxygenase-2) — the enzyme target of NSAIDs — and 5-LOX (lipoxygenase). This makes it mechanistically interesting for chronic inflammation, joint pain, and metabolic syndrome. Aggarwal et al., 2009, Ann NY Acad Sci In vitro confirmed

The problem: curcumin has less than 1% oral bioavailability in standard formulations. Phase I and II rapid metabolism by intestinal glucuronidases and sulfotransferases converts curcumin to inactive conjugates before it reaches systemic circulation. Raw turmeric powder (~3–5% curcuminoids) delivers perhaps 1–2mg to blood from a teaspoon dose. Three approaches have meaningful clinical evidence for improving this:

Raw turmeric

<1%

Baseline absorption — mostly undetected in serum at typical doses

+ BioPerine (5mg)

20×

Piperine inhibits intestinal glucuronidases. Shoba et al. 1998.

BCM-95 / Biocurcumin

7×

Turmeric essential oil complex — phospholipid-independent. Antony et al. 2008.

Meriva (Phytosome)

29×

Phosphatidylcholine complex. Cuomo et al. 2011.

Clinical evidence for curcumin in osteoarthritis, inflammatory bowel disease, and metabolic syndrome has accumulated in 20+ RCTs — all using enhanced-bioavailability formulations. None of this evidence applies to raw turmeric powder or basic turmeric extract without a declared absorption enhancer. Daily et al., 2016, J Med Food Meta-analysis

Bacopa monnieri: memory via acetylcholinesterase inhibition

Bacopa monnieri (brahmi) improves delayed recall memory through multiple mechanisms. Bacosides A and B — the primary active saponins — inhibit acetylcholinesterase (AChE), the enzyme that degrades acetylcholine at the synapse, effectively increasing cholinergic neurotransmission. Bacosides also activate protein kinase activity in the hippocampus and increase synaptic density. Additionally, Bacopa exhibits antioxidant activity via metal chelation and free radical scavenging — reducing oxidative stress in hippocampal neurons. Roodenrys et al., 2002, Neuropsychopharmacology RCT

Critical timing note: Bacopa is not an acute cognitive enhancer. The memory improvements documented in RCTs appear at 8–12 weeks of consistent daily dosing — not within hours or days of the first dose. This makes the supplement category vulnerable to premature discontinuation and negative user reviews from people who stopped at week 3. At 300mg/day of extract standardised to 45% bacosides, or 450mg/day at 20% bacosides, the evidence for delayed memory recall improvement is robust across 9 double-blind RCTs. Kongkeaw et al., 2014, J Ethnopharmacol Meta-analysis

Berberine: AMPK activation comparable to metformin

Berberine is an isoquinoline alkaloid from Berberis aristata (daruharidra — Indian barberry) and other Berberis species. Its primary metabolic mechanism is AMPK (AMP-activated protein kinase) activation — the same energy-sensing enzyme targeted by metformin. AMPK activation in hepatocytes suppresses gluconeogenesis (reducing fasting glucose) and increases insulin receptor expression. Berberine also inhibits mitochondrial complex I in a dose-dependent manner, which reduces cellular ATP/AMP ratio and secondarily activates AMPK. Zhang et al., 2008, Metabolism RCT

Three head-to-head RCTs against metformin in type 2 diabetics have found statistically equivalent HbA1c and fasting glucose reduction at 500mg berberine three times daily. Zhang et al. (2008) is the most-cited: −0.9% HbA1c and −1.0 mmol/L fasting glucose for both berberine and metformin. Berberine also significantly improved lipid profiles (LDL −21%, TG −35%, HDL +5%) — outcomes not replicated to the same degree by metformin. Critically: berberine interacts with CYP3A4 substrates and may increase the plasma levels of statins and cyclosporine. Dong et al., 2012, Altern Ther Health Med Meta-analysis

Fig. 1 — Curcumin (NF-κB/COX-2), Bacopa (AChE/cholinergic), Berberine (AMPK/glucose) — the three pathways with strongest human RCT evidence in this category.

India market context

A country with the world's best herbs — and the worst herbal labelling

~80%

Indian households that use some form of traditional herbal medicine regularly. This cultural familiarity with herbs creates trust — and a purchasing reflex that supplement brands exploit by using Ayurvedic herb names on standardised extract products, or by using clinical extract evidence to market churna products.

AYUSH

The Ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha, Homeopathy) regulates traditional preparations under the Drugs and Cosmetics Act. AYUSH approval does NOT mean clinical efficacy — it means the product meets standards for traditional use. Brands displaying AYUSH registration as proof of clinical effectiveness are misrepresenting what the approval means.

No %

Required minimum active compound content for herbal supplements under FSSAI 2022 regulations. A curcumin product can declare 0% curcuminoids and remain FSSAI compliant. A bacopa product need not state bacoside content. This regulatory gap is why standardisation declarations on labels are brand-voluntary, not mandatory — and why they matter.

B.aristata

Berberis aristata (daruharidra) is native to the Himalayan foothills and used in traditional Indian medicine. India is a primary source of raw berberine — yet most Indian berberine supplement products in the organised market use imported Chinese raw material. Indian-sourced berberine with documented berberine HCl percentage is rare.

500mg

The dose used in head-to-head berberine vs metformin RCTs — taken three times daily with meals. Most Indian berberine products provide 500mg per capsule, requiring 3 capsules/day at mealtimes. At ₹699/60 caps, this is a 20-day supply at therapeutic dose — roughly ₹35/day.

12 weeks

The minimum supplementation window required to see meaningful Bacopa monnieri effects on delayed recall memory. RCTs showing null results for Bacopa often used 4–6 week periods — below the established onset window. Buyers who try Bacopa for two weeks and see no effect are drawing the wrong conclusion. The biological mechanism (AChE inhibition + synaptic remodelling) requires sustained exposure.

Label intelligence

How to read an Indian herbal supplement label

Good signals

95%

Standardisation percentage explicitly stated

A label that states "Curcumin 95% curcuminoids," "Bacopa extract standardised to 45% bacosides," or "Berberine HCl 98% pure" is making a quantitative, testable commitment. This is the minimum requirement for evaluating whether the product matches what was used in clinical trials. Without a stated percentage, the phrase "Turmeric extract" or "Brahmi extract" is meaningless for efficacy prediction.

Bio

Absorption enhancer declared for curcumin

Look for: BioPerine (piperine 5mg), BCM-95, Biocurcumin, Meriva, or "with phosphatidylcholine" on curcumin products. These are not marketing additions — they are mechanistically essential. A curcumin product without any of these has essentially no systemic bioavailability at standard doses. The RCT evidence does not apply to it. Carbamide Forte, NOW, and Nutrabay Gold include BioPerine in their curcumin products.

Lat

Latin species name on the label

"Bacopa monnieri" vs "Brahmi" — the Latin name is an unambiguous commitment to the species. "Brahmi" can mean either Bacopa monnieri or Centella asiatica depending on regional tradition. For cognitive applications, you want Bacopa monnieri specifically. For curcumin: "Curcuma longa" confirmed. For berberine: "Berberis aristata" (Indian) or "Berberis vulgaris" (acceptable). Both species have comparable berberine content.

COA

NABL COA or third-party certificate available

Most herbal supplements will not have proactively published NABL COAs — the category is behind protein and creatine on transparency. However, brands that provide documentation on request are meaningfully more trustworthy than those with no testing documentation at all. For berberine specifically, heavy metal testing matters — Berberis root accumulates soil metals.

Red flags

"Haldi extract" or "Turmeric extract" without curcuminoid % or bioavailability enhancer

This describes raw turmeric powder or a basic extract with essentially no systemic curcumin delivery. The product may be 100% pure, FSSAI compliant, and entirely unable to produce any of the anti-inflammatory effects demonstrated in curcumin RCTs. This label pattern covers the majority of Indian "haldi supplement" products. If there is no BioPerine, phospholipid complex, or stated curcuminoid % with absorption data, the product is not a clinical curcumin supplement.

Multi-herb blends with 15–30 ingredients and undisclosed per-herb amounts

Indian "immunity booster" and "liver health" blends frequently contain 15–30 herbs in a single capsule. At 500mg total, with 20 herbs, the average herb content is 25mg — nowhere near a therapeutic dose of anything. These products are not harmful, but they are also not delivering clinical outcomes for any single herb. The label typically shows a "proprietary blend" weight without per-ingredient disclosure. This is the herbal equivalent of amino spiking in protein.

AYUSH registration displayed prominently alongside clinical health claims

AYUSH approval certifies that a product meets standards for traditional Ayurvedic medicine. It does not certify clinical efficacy by any standard used in peer-reviewed research. A churna with AYUSH approval can make traditional use claims ("used in Ayurveda for digestion") but not clinical claims ("clinically proven to improve digestion"). Many brands use the AYUSH logo to imply clinical validation without stating it explicitly — a regulatory grey zone that misleads consumers.

Berberine from unlisted or uncharacterised source

Berberine is found in multiple plant species with variable content. "Berberine 500mg" without a source plant or purity declaration could be anything from 60–98% berberine HCl. Heavy metal contamination (lead, arsenic) has been documented in uncharacterised Berberis root materials. For a compound being used at metabolic-therapeutic doses, source and purity matter. Prefer products stating "Berberis aristata standardised to X% berberine HCl" with heavy metal testing documentation.

Scored picks

Top 5 herbal supplement picks for India 2026

Scored on: standardisation % · absorption/bioavailability · RCT-matched dose · purity documentation · label honesty

#1 — Best curcumin for India

8.7

Carbamide Forte

Curcumin 95% with BioPerine 500mg

₹799

90 veg caps · ₹8.9/day

Carbamide Forte Curcumin 95% with BioPerine 500mg

Buy on Amazon ↗

95% curcuminoids — declared BioPerine 5mg — 2000% bioavailability boost 500mg per capsule — RCT range FSSAI licensed · Vegetarian

Dose (9.0/10): 500mg curcumin at 95% curcuminoids = 475mg curcuminoids per capsule. The anti-inflammatory RCT dose range is 200–1,500mg curcuminoids/day with BioPerine. One to two capsules places the user in the evidence-backed window for joint pain and systemic inflammation outcomes.

Bioavailability (10/10): 5mg piperine (BioPerine) per capsule. Shoba et al. (1998) demonstrated a 2,000% increase in curcumin serum AUC with this co-administration. This is the non-negotiable requirement for curcumin to be a functional anti-inflammatory supplement rather than an expensive yellow powder.

Value (9.5/10): At ₹8.9/day for one capsule (or ₹17.8 at two caps), this is the most affordable effective curcumin+BioPerine product in India. The curcuminoid declaration and BioPerine inclusion confirm clinical-grade formulation intent.

Do not take within 30 minutes of medications — BioPerine (piperine) inhibits intestinal and hepatic enzymes that metabolise many drugs, including blood thinners, antibiotics, and statins. This is not a reason to avoid curcumin, but timing matters. Separate from any medication by 2 hours.

#2 — Best Bacopa for memory

8.5

NOW Supplements

Bacopa Extract 450mg (55% bacosides)

₹1,499

90 veg caps · ₹16.7/day

NOW Supplements Bacopa Extract 450mg (55% bacosides)

Buy on Amazon ↗

55% bacosides — highest available Bacopa monnieri — Latin name confirmed 450mg — above RCT minimum dose NOW quality standards Take with food — GI discomfort fasted

Standardisation (10/10): 55% bacosides A+B is the highest standardisation available in a commercially accessible product — delivering 247.5mg active bacosides per 450mg capsule. Most Indian bacopa products use 20% bacosides. At the same capsule dose, NOW delivers 2.75× the active compound concentration.

The critical expectation-setting: This supplement will not make you sharper next week. The Roodenrys et al. (2002) and Kongkeaw et al. (2014) meta-analysis memory improvements emerge at 8–12 weeks of consistent daily use. Commit to a 90-day minimum evaluation window before concluding anything.

Take with the largest meal of the day. Bacopa commonly causes GI discomfort (nausea, cramping) when taken fasted — this side effect is dose-dependent and almost entirely avoided with food co-administration. The 90 capsule bottle lasts exactly 90 days at one capsule daily — a convenient 3-month trial design.

#3 — Best berberine for metabolic health

8.6

Carbamide Forte

Berberine HCl 500mg

₹799

60 caps · ₹40/day at 3 caps

Buy on Amazon ↗

Berberine HCl — salt specified 500mg/cap — RCT therapeutic dose FSSAI licensed 3 caps/day needed (1500mg total) CYP3A4 interaction — check medications

The metabolic herb with the strongest clinical case in this guide. Three head-to-head RCTs against metformin 500mg TID found statistically equivalent HbA1c reduction (−0.9%) and fasting glucose reduction (−1.0 mmol/L). Zhang et al. (2008) is the most rigorous: 116 patients, 3 months, randomised. Berberine's additional lipid effects (LDL −21%, TG −35%) may actually give it an advantage over metformin for combined metabolic syndrome management. Zhang et al., 2008, Metabolism

Important positioning: Berberine is not a replacement for prescribed diabetes medication. Its evidence base is in pre-diabetes, metabolic syndrome, and as adjunct therapy. Anyone on diabetes medication who considers adding berberine must do so under physician supervision — the additive glucose-lowering effect can cause hypoglycaemia.

At ₹799/60 caps (3 caps/day = 20 days), the per-day cost is ₹40. Consider the 120-cap version for a 40-day therapeutic trial at therapeutic dose. CYP3A4 interaction is real: berberine inhibits this liver enzyme, increasing plasma concentration of statins, cyclosporine, and some antibiotics. Inform your doctor if you are on any long-term medication.

#4 — Best Shatavari (women's health)

8.1

Himalaya

Shatavari 250mg Standardised 60ct

₹320

60 tablets · ₹5.3/day

Himalaya Shatavari 250mg Standardised 60ct

Buy on Amazon ↗

Asparagus racemosus — species confirmed Himalaya standardisation process 250mg dry extract FSSAI + AYUSH compliant Moderate RCT evidence base

The most trusted Indian pharmaceutical brand's Shatavari product. Asparagus racemosus root contains steroidal saponins (shatavarins I–V) with mild phytoestrogenic activity — relevant for menopausal symptoms, lactation support, and menstrual irregularity. Himalaya's extraction process is more rigorously standardised than most generic ayurvedic brands, and their 60-year research history in herbal standardisation gives credibility to their extract quality even when active compound % is not declared on the label.

The RCT evidence for shatavari is moderate — smaller trials with mixed outcomes. The indication with the most clinical support is galactagogue effect (increased breast milk production): two RCTs confirm benefit vs placebo. Menopausal symptom data is promising but requires larger trials.

Shatavari has mild phytoestrogenic activity — it binds estrogen receptors weakly. In women with hormone-sensitive conditions (estrogen-receptor positive breast cancer history), use only under oncologist guidance. This is a precautionary note, not a contraindication in the general population, where the estrogenic effect at standard doses is clinically minor.

#5 — Best Boswellia (joint/inflammation)

8.4

Carbamide Forte

Boswellia Extract 500mg (65% boswellic acids)

₹699

60 caps · ₹11.65/day

Carbamide Forte Boswellia Extract 500mg (65% boswellic acids)

Buy on Amazon ↗

65% boswellic acids — declared Boswellia serrata — Indian species confirmed 5-LOX inhibitor — distinct from NSAIDs FSSAI licensed

The non-NSAID anti-inflammatory with the most relevant India positioning. Boswellia serrata (shallaki) is native to India. Boswellic acids — specifically AKBA (acetyl-11-keto-beta-boswellic acid) — selectively inhibit 5-lipoxygenase (5-LOX), blocking leukotriene synthesis. This is a different anti-inflammatory pathway to NSAIDs (which inhibit COX-1/COX-2), making it complementary rather than redundant. No gastrointestinal bleeding risk — the primary NSAID side effect.

Kimmatkar et al. (2003) found 333mg Boswellia extract three times daily significantly reduced pain and improved function vs placebo in knee osteoarthritis over 8 weeks. Kimmatkar et al., 2003, Phytomedicine At 500mg once or twice daily, the Carbamide Forte product is in the RCT-supported dose range.

Take with food. Boswellic acids have modest gastrointestinal side effects at high doses — take with the main meal. Not a rapid-acting painkiller; anti-inflammatory effects build over 4–8 weeks. Combine with curcumin+BioPerine for additive anti-inflammatory effect via complementary pathways (5-LOX + COX-2/NF-κB).

All 85 products

Full comparison 85

Sorted by score within herb
Churna scored on own merits, not vs extracts

Score	Brand	Product	Herb	Standardisation	Key dose	Price	Flag
CURCUMIN / TURMERIC
8.7A	Carbamide Forte	Curcumin 95% + BioPerine 500mg 90ct	Curcuma longa	95% curcuminoids + BioPerine	500mg	₹799	Best value curcumin India
8.6A	NOW	Curcumin Phytosome 500mg 60ct	Curcuma longa	Meriva phospholipid complex	500mg	₹1,799	29× bioavailability — phospholipid
8.5A	Nutrabay Gold	Curcumin 1000mg + BioPerine 90ct	Curcuma longa	95% curcuminoids + BioPerine	1000mg	₹899	Higher dose — 2 gram range
8.3A	TrueBasics	Turmeric Curcumin with BioPerine 60ct	Curcuma longa	95% curcuminoids + BioPerine	500mg	₹899	—
8.2A	Solgar	Full Spectrum Curcumin 60ct	Curcuma longa	LongVida lipidated — high BA	400mg	₹2,499	LongVida patented form — 285× increase
8.0A	Himalaya	Curcumin with Piperine 60ct	Curcuma longa	Standardised + piperine	500mg	₹699	Himalaya extraction standard
7.8B+	OZiva	Curcumin C3 Complex 60ct	Curcuma longa	C3 Complex (Sabinsa) + BioPerine	500mg	₹999	Sabinsa patented C3 Complex
6.8B-	Organic India	Turmeric Formula 60ct	Curcuma longa	No bioavailability enhancer declared	400mg	₹799	Organic — but no piperine/phospholipid
6.5C+	WOW Life Science	Turmeric Curcumin 60ct	Curcuma longa	Extract % not declared	500mg	₹599	No standardisation disclosure
5.0C-	Patanjali	Haldi Churna 200g	Curcuma longa powder	Raw churna — no standardisation	Churna	₹99	FLAG: <1% systemic curcumin without enhancer
BACOPA MONNIERI (BRAHMI)
8.5A	NOW	Bacopa Extract 450mg 55% bacosides 90ct	Bacopa monnieri	55% bacosides A+B	450mg	₹1,499	Highest bacoside standardisation available
8.4A	Himalaya	Brahmi (Bacopa) 60ct	Bacopa monnieri	Standardised dry extract	300mg	₹319	Best value standardised bacopa India
8.2A	Carbamide Forte	Bacopa Monnieri 500mg 20% bacosides 60ct	Bacopa monnieri	20% bacosides declared	500mg	₹599	—
8.0A	Nutrabay Gold	Bacopa Monnieri 300mg 45% bacosides 60ct	Bacopa monnieri	45% bacosides declared	300mg	₹699	—
7.8B+	Naturaltein	Bacopa Extract 300mg 60ct	Bacopa monnieri	Standardised — % on request	300mg	₹599	NABL COA available
7.0B	Organic India	Brahmi 60ct	Bacopa monnieri + Centella	Mixed species — no bacoside %	400mg	₹699	Mixed Brahmi species — verify Bacopa monnieri content
5.0C-	Dabur	Brahmi Vati tablets	Mixed traditional formula	Traditional preparation — no standardisation	Traditional	₹149	Ayurvedic product — not a clinical supplement
BERBERINE
8.6A	Carbamide Forte	Berberine HCl 500mg 60ct	Berberis aristata	Berberine HCl — salt specified	500mg	₹799	Best India berberine — source declared
8.5A	NOW	Berberine Glucose Support 400mg 90ct	Berberis aristata	400mg berberine HCl	400mg	₹1,599	Lower dose vs RCT (500mg) — take 4 caps/day
8.3A	TrueBasics	Berberine 500mg 60ct	Berberis aristata	500mg berberine	500mg	₹999	—
8.0A	GNC	Herbal Plus Berberine 500mg 60ct	Berberis spp.	500mg — source unspecified	500mg	₹1,399	GNC authorised — source not declared
7.5B	Nutrabay	Berberine 500mg 60ct	Berberis spp.	500mg — no source	500mg	₹699	No source plant declared
BOSWELLIA (SHALLAKI)
8.4A	Carbamide Forte	Boswellia 500mg 65% boswellic acids 60ct	Boswellia serrata	65% boswellic acids	500mg	₹699	Indian species — 5-LOX inhibitor
8.2A	NOW	Boswellia Extract 500mg 90ct	Boswellia serrata	65% boswellic acids	500mg	₹1,399	—
8.1A	Himalaya	Shallaki (Boswellia) 60ct	Boswellia serrata	Standardised Himalaya extract	250mg	₹329	Lower dose — combine with curcumin
7.9B+	Nutrabay Gold	Boswellia 65% 60ct	Boswellia serrata	65% boswellic acids	500mg	₹799	—
SHATAVARI
8.1A	Himalaya	Shatavari 250mg 60ct	Asparagus racemosus	Himalaya standardisation	250mg	₹320	Most trusted Indian shatavari
7.8B+	Nutrabay Gold	Shatavari 500mg 60ct	Asparagus racemosus	Dry extract	500mg	₹699	—
7.5B	Organic India	Shatavari 60ct	Asparagus racemosus	Organic powder + extract	500mg	₹799	Organic certification — no saponin %
MORINGA
8.0A	Organic India	Moringa Leaf Powder 60ct	Moringa oleifera	Organic leaf — dense micronutrient	500mg leaf	₹649	Moringa is a food — not an extract
7.9B+	NOW	Moringa 400mg 90ct	Moringa oleifera	Leaf extract standardised	400mg	₹1,299	—
7.7B+	TrueBasics	Moringa 500mg 60ct	Moringa oleifera	Leaf extract	500mg	₹799	—
MULTI-HERB BLENDS — REVIEW CAREFULLY
5.5C	Various	Chyawanprash-style multi-herb immunity blends	Multiple herbs (15–30)	Undisclosed per-herb amounts	Proprietary blend	₹499–999	FLAG: per-herb doses likely subtherapeutic for each
5.0C-	Multiple	"Liver detox" blends 20+ herbs	Multiple herbs	No standardisation — blend weight only	Blend	₹599–1,499	FLAG: no single herb at clinical dose
TRADITIONAL HERBS — FOOD-RANGE EVIDENCE
7.2B	Himalaya	Triphala 60ct	Terminalia + Phyllanthus	Standardised blend	500mg	₹209	Digestive support — limited clinical data
7.0B	Himalaya	GudUchi (Giloy) 60ct	Tinospora cordifolia	Standardised extract	250mg	₹299	Immune modulation — moderate evidence
6.8B-	Organic India	Amla 60ct	Phyllanthus emblica	Whole fruit extract	500mg	₹599	High Vit C + tannins — food-range evidence

Brand-level trust ratings

Herbal brand verdicts — India

Himalaya Drug Company

VERIFIED

The most trustworthy Indian herbal brand for standardised extracts — by a significant margin. Himalaya's 90-year research history in phytopharmaceuticals and their internal standardisation methodology produce more consistent active compound delivery than most Indian supplement brands. They publish peer-reviewed research on their own extracts. The Bacopa (Brahmi), Shatavari, Boswellia (Shallaki), and Triphala products have better extraction consistency than the comparable market price would suggest. Himalaya products are pharmaceutical-grade in their standardisation process, even at the ₹200–350 price point.

ExtractionProprietary validated

ResearchIn-house publications

Avg score7.9–8.4

Carbamide Forte

VERIFIED

The best Indian brand for science-first herbal formulations. Carbamide Forte consistently makes the correct formulation decisions: BioPerine with curcumin, berberine HCl (not generic berberine), boswellic acid percentage stated. These are not default industry choices — most Indian brands omit them. At competitive pricing with documentation available on request, Carbamide Forte represents the best accessible combination of formulation science and price in the Indian herbal category.

BioPerineincluded with curcumin

Std %declared on label

Avg score8.4–8.7

Organic India

MIXED

Organic certification without sufficient clinical formulation discipline. Organic India's products have rigorous organic sourcing standards and clean supply chains. Their Tulsi, Moringa, and Ashwagandha products serve their intended purpose as food-range organic supplements. The problem: their Turmeric Formula lacks an absorption enhancer, and their Brahmi uses a mixed-species formulation without per-species bacoside disclosure. Organic purity is important; without standardisation and bioavailability engineering, it is not sufficient for clinical-grade herbal supplementation.

Organiccertified standard

BioPerineabsent from curcumin

Avg score6.8–8.0

Patanjali / Baidyanath

WRONG CATEGORY

Traditional Ayurvedic manufacturers — not clinical supplement brands. Same verdict as ashwagandha. Patanjali and Baidyanath produce legitimate traditional preparations with cultural and historical validity. Their churnas and arishtas are Ayurvedic medicines in the original sense. They are not standardised extracts with RCT-backed efficacy data. When sold alongside Carbamide Forte curcumin or Himalaya Bacopa on the same Amazon search page with similar health claims, the category confusion harms consumers who substitute churna for a clinical extract expecting the same outcomes.

CategoryTraditional medicine

NotClinical supplements

Avg score4.5–5.5

NOW Supplements (India)

VERIFIED

Reliable standardisation and species confirmation across the range. NOW's Bacopa (55% bacosides), Boswellia (65% boswellic acids), and Berberine products all state standardisation percentages and use the correct Latin species names. Third-party testing standards applied. As an import brand, pricing is 1.5–2.5× the Indian equivalent, but for herbs where standardisation documentation matters most (Bacopa, Berberine), the NOW premium is partially justified by the higher bacoside concentration.

Bacopa55% bacosides

Berberinesource declared

Avg score8.2–8.6

Multi-herb "Immunity Boost" brands

AVOID

Branded dilution of every herb they contain. Products with 15–30 herbs in a single capsule are mathematically unable to deliver a therapeutic dose of any individual herb. A 500mg capsule containing 20 herbs averages 25mg per herb — Bacopa's minimum effective dose is 300mg; curcumin's is 500mg. These products exist because multi-herb marketing allows broad health claims: when no single herb is dosed to efficacy, no single herb can fail clinically. The product is immune to disproof. Buy targeted single-herb or two-herb combinations at known doses instead.

Per-herb dosesubtherapeutic

Claimsnot falsifiable

Avg score4.5–5.5

Frequently asked

Herbal supplements — the precise questions

If I cook with turmeric daily, do I still need a curcumin supplement?

For culinary purposes, turmeric in food is culturally important and contributes some antioxidant benefit from the polyphenol content. However, for the anti-inflammatory outcomes demonstrated in RCTs — joint pain reduction, CRP lowering, metabolic improvement — culinary turmeric cannot substitute for a bioavailable curcumin supplement. Cooking with turmeric in oil (as in traditional Indian cooking) does improve curcumin absorption somewhat vs dry powder alone, but not to the degree achieved by piperine or phospholipid complexes. Shoba et al., 1998, Planta Medica The cooking-with-oil method is not the same as the BioPerine method pharmacokinetically — the absorption enhancement mechanisms are different and the data is not equivalent.

Can I take curcumin and berberine together?

Mechanistically, they are complementary — curcumin primarily inhibits NF-κB and COX-2; berberine primarily activates AMPK and suppresses gluconeogenesis. There is no known pharmacodynamic antagonism between them. However, both compounds interact with CYP3A4: berberine inhibits it (increasing plasma levels of some co-administered drugs), and curcumin has modest CYP3A4 inhibition as well. The combined CYP inhibition is a consideration if you are on any long-term medication — discuss with your physician. For someone without chronic medication, the combination is reasonable for metabolic syndrome support.

Is berberine safe long-term?

The longest human RCTs have run 3–6 months. Long-term safety data beyond 12 months is limited. At 1,500mg/day (500mg × 3), GI side effects (nausea, constipation, diarrhoea) are the primary complaint — typically dose-dependent and managed by taking with food. There is no evidence of organ toxicity at standard doses in short-to-medium term use. The CYP3A4 interaction warrants caution in anyone on regular medication. As with any compound with strong pharmacological effects, cycling (3 months on, 1 month off) is a reasonable precautionary approach for long-term use in the absence of longer safety trials.

Why does "Brahmi" sometimes mean different herbs?

"Brahmi" is a vernacular name applied to two botanically distinct plants in Ayurvedic tradition: Bacopa monnieri (water hyssop — used predominantly in South India and the basis of cognitive RCTs) and Centella asiatica (gotu kola, mandukparni — used in North India and in collagen/wound-healing research). They have completely different active compounds, different mechanisms, and different evidence bases. Roodenrys et al., 2002 When buying a cognitive Brahmi supplement, verify the Latin name is Bacopa monnieri and that bacosides A+B are standardised and declared.

Is Giloy (Guduchi) effective for immunity?

Giloy (Tinospora cordifolia) has moderate RCT evidence for immune modulation in specific contexts. It has been studied as an adjunct in dengue fever management (fever duration and platelet count), allergic rhinitis, and as a potential anti-malarial. The immunostimulant effect is mediated by polysaccharides and alkaloids that stimulate macrophage phagocytosis. Gupta et al., 2017 This is not the same as "preventing colds and flu" — a claim commonly made by Indian brands. For general "immunity boost" use, the evidence is limited and non-specific. The dengue and rhinitis data is more targeted and more credible. FSSAI does not permit Giloy products to claim they "prevent dengue."

What is the difference between Boswellia serrata and Boswellia sacra?

Boswellia serrata (shallaki) is the Indian species — native to the dry hills of India and the species used in all clinically validated anti-inflammatory trials. Boswellia sacra is the Arabian species (frankincense) used primarily for aromatic resin. For joint pain and anti-inflammatory applications, only B. serrata has the supporting RCT evidence. Most Indian products correctly use B. serrata. When buying imported boswellia (especially aromatherapy-adjacent brands), confirm the species is serrata, not sacra or carterii.

Primary literature

References & sources

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64(4), 353–356. doi:10.1055/s-2006-957450 — The foundational piperine+curcumin bioavailability study.
Aggarwal BB, Sung B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences, 30(2), 85–94. doi:10.1016/j.tips.2008.11.002
Daily JW, Yang M, Park S. (2016). Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. Journal of Medicinal Food, 19(8), 717–729. doi:10.1089/jmf.2016.3705 Meta-analysis
Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. (2002). Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology, 27(2), 279–281. doi:10.1016/S0893-133X(01)00419-5
Stough C, Lloyd J, Clarke J, et al. (2001). The chronic effects of an extract of Bacopa monniera on cognitive function in healthy human subjects. Psychopharmacology, 156(4), 481–484. doi:10.1007/s002130100815
Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology, 151(1), 528–535. doi:10.1016/j.jep.2013.11.008
Zhang Y, Li X, Zou D, et al. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology & Metabolism, 93(7), 2559–2565. doi:10.1210/jc.2007-2404 — Berberine vs metformin head-to-head.
Dong H, Wang N, Zhao L, Lu F. (2012). Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine, 2012, 591654. doi:10.1155/2012/591654
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. (2003). Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee — a randomized double blind placebo controlled trial. Phytomedicine, 10(1), 3–7. doi:10.1078/094471103321648593
Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. (2008). A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (biocurcumin). Indian Journal of Pharmaceutical Sciences, 70(4), 445–449. doi:10.4103/0250-474X.44591
Cuomo J, Appendino G, Dern AS, et al. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products, 74(4), 664–669. doi:10.1021/np1007262
Gupta P, Singh UP, Bhatt DL, et al. (2017). Tinospora cordifolia (Giloy): a versatile drug. Journal of Pharmacognosy and Phytochemistry, 6(4), 166–168.
FSSAI. (2022). Food Safety and Standards (Health Supplements, Nutraceuticals, etc.) Regulations, 2022. Food Safety and Standards Authority of India, New Delhi.
Ministry of AYUSH. (2021). Good Manufacturing Practices for Ayurvedic, Siddha and Unani Medicines. Ministry of AYUSH, Government of India, New Delhi.

Scoring: five dimensions (standardisation %, absorption engineering, RCT-matched dose, purity documentation, label honesty) 0–10, unweighted. Churna and traditional preparations scored in their own category — not penalised for being traditional products, but scored on clinical supplementation fit. Updated May 2026. No brand paid for placement. Conflicts policy